Notes & TipsEvaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST
Section snippets
Acknowledgment
We thank Professor Masafumi Yohda (Tokyo University of Agriculture and Technology) for extensive review of the manuscript.
References (11)
- et al.
Point-of-care testing and cardiac biomarkers: The standard of care and vision for chest pain centers
Cardiology
(2005) - et al.
Development of a novel method of operating magnetic particles, Magtration technology, and its use for automating nucleic acid purification
J. Biosci. Bioeng.
(2001) - et al.
Cardiac markers: Centralized or decentralized testing?
Clin. Chem. Lab. Med.
(1999) - Joint European Society of Cardiology/American College of Cardiology Committee, Myocardial infarction redefined: A...
- National Academy of Clinical Biochemistry, National Academy of Clinical Biochemistry laboratory medicine practice...
Cited by (48)
Point-of-care diagnostics for infectious diseases: From methods to devices
2021, Nano TodayCitation Excerpt :As early as in 2002, an accurate and sensitive chemiluminiscence POC diagnostics, called the ZstatFlu®-II test, for the detection of influenza virus infections was developed, which has already been commercialized [214,215]. Besides, other commercialized chemiluminiscence biosensors based POC devices, such as FastPack® IP system, PATHFAST®, OPTIGEN® systems, and so on, have also been developed [212,216,217]. However, those devices did not meet the “ASSURED” standard absolutely, which still required complicated operation and complex detector devices.
Prediction of presepsin concentrations through commensurate decline in kidney function in the elderly
2020, Clinica Chimica ActaComparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury
2019, Clinica Chimica ActaCitation Excerpt :Based on these groups, we compared the patients' ages, sex, white blood cell counts, hematocrit concentrations, platelet counts, albumin concentrations, C-reactive protein (CRP) concentrations, creatinine (Cr) concentrations, lactate concentrations, PCT concentrations, P-SEP concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) II [22], and SOFA scores [18] at admission. P-SEP concentrations were measured using a compact automated immunoanalyzer (Pathfast®; LSI Medience Corp.) based on a chemiluminescent enzyme immunoassay [23,24]. PCT concentrations were measured using the Elecsys Brahms PCT assay (Roche Diagnostics).
An experimental ovine Theileriosis: The effect of Theileria lestoquardi infection on cardiovascular system in sheep
2016, Acta TropicaCitation Excerpt :After forming the clot, the blood samples were centrifuged at 1800g rpm for 10 min, and the serum sample was isolated and kept at −80 °C until the experiment was performed. The cTnI amount of the serum samples were measured by chemiluminescent (CLIA) technique (Kurihara et al., 2008) and commercial kit (LIAISON® Troponin I, DiaSorin, Saluggia, Italy). Moreover, the autoanalyzer (Biotecnica, BT 1500, Rome, Italy) and commercial kits (Pars Azmoon, Tehran, Iran) were used for measuring aspartate transaminase, l-aspartate/2-oxoglutrate as substrate (AST), lactate dehydrogenase, DGKC: P-L (LDH), and creatine phosphokinase, creatine phosphate as a substrate (CPK) activities (Thomas et al., 1998).
Diagnostics on acute myocardial infarction: Cardiac troponin biomarkers
2015, Biosensors and Bioelectronics
- 1
Current address: PATHFAST Group, POCT Business Department, Mitsubishi Chemical Medience Corporation, 2-8 Shibaura, 4 Minato, Tokyo 108-8559, Japan.